Home › Activist investors › Engaged Capital
Campaign activist. Positions and campaigns from Engaged Capital’s SEC filings. Updated November 20, 2026.
No active campaign by this definition (see How to read this).
| Company | Stake | Source | First disclosed | Last change | Since previous filing | Flags | Stated intent |
|---|---|---|---|---|---|---|---|
| Evolent Health, Inc. | 4.45%5,032,806 shares | 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Oct 30, 2026 | Nov 16, 2020 | Decreased Nov 16, 2026 | ▼ 0.47 pts | Decreased | 13F: none stated |
| YETI Holdings, Inc. | 2.35%1,714,095 shares | 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Aug 6, 2026 | May 15, 2025 | Increased Nov 16, 2026 | ▲ 0.71 pts | Increased | 13F: none stated |
| Portillo'S Inc. | 2.09%1,507,990 shares | 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Mar 29, 2026 | May 15, 2024 | Decreased Nov 16, 2026 | ▼ 2.68 pts | Decreased | 13F: none stated |
| VF Corporation | 1.43%5,618,894 shares | 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Oct 24, 2026 | Nov 14, 2023 | Increased Nov 16, 2026 | ▲ 0.28 pts | Increased | 13F: none stated |
| BRC Inc. | 12.7%14,597,791 shares | Schedule 13D/A, filed Jan 21, 2026 | Jul 3, 2023 | Increased Jan 21, 2026 | ▼ 0.10 pts | — | Standard Item 4 language |
Stake: the latest 13D’s percent of the class (the largest single reporting person’s, as filed), or for a 13F the reported shares as a percent of the company’s shares outstanding on the date shown. Since previous filing: the change in percentage points against the investor’s previous 13D on the company, or its previous 13F.
Item 4 of a Schedule 13D (“Purpose of Transaction”) is where the investor states its plans. The label is a plain reading of that text; the excerpt is quoted from the filing.
“Item 4 is hereby amended to add the following: On July 18, 2025, Engaged Capital Flagship Master purchased 400,000 Shares in the Issuer's underwritten public offering (the "Offering") at the public offering price of $1.25 per Share. In connection with the Offering, Engaged Capital Flagship Master entered into a customary lock-up agreement with the underwriter (the "Lock-Up Agreement"), pursuant to”
Item 4 in the Schedule 13D/A filed Jan 21, 2026; this amendment did not restate Item 4, so the text is from the filing of Jul 22, 2025.
Campaigns are compiled from SEC filings (13D, proxy contest filings and settlement 8-Ks); campaigns run without SEC filings, e.g. by public letter below the 5% threshold, may not appear.
| Company | Outcome or last status | Date | First filing | Highest stage | Filings | Meeting / votes |
|---|---|---|---|---|---|---|
| Blackline, Inc. | Settled (agreement with the company) | Mar 10, 2026 | Jan 13, 2026 | Soliciting material filed | latest (8) | — |
| Portillo's Inc.Board seats | Stake reported below 5% | Oct 22, 2025 | Aug 15, 2024 | Nominations made | latest (8) | — |
| YETI Holdings, Inc.Board seats | Settled — 2 board seats | Mar 17, 2025 | Mar 17, 2025 | — | latest (1) | — |
| Evolent Health, Inc. | Settled (agreement with the company) | Dec 22, 2020 | Aug 20, 2020 | — | latest (3) | — |
| Nevro Corp | Stake reported below 5% | Nov 14, 2024 | Dec 11, 2023 | — | latest (4) | — |
| Quotient Technology Inc.Board seats | Stake reported below 5% | Jul 7, 2023 | Nov 17, 2021 | Proxy contest filed (preliminary proxy) | latest (7) | — |
| Shake Shack Inc. | Settled (agreement with the company) | May 16, 2023 | May 16, 2023 | — | latest (1) | — |
| Upbound Group, Inc.Board seats | Settled (agreement with the company) | Feb 7, 2018 | Jan 30, 2017 | Proxy contest filed | latest (21) | — |
| New Relic, Inc. | Settled (agreement with the company) | Jun 25, 2021 | Jun 25, 2021 | — | latest (1) | — |
| OneSpan Inc. | Settled (agreement with the company) | May 20, 2021 | May 20, 2021 | — | latest (1) | — |
| Medifast Inc | Settled (agreement with the company) | Apr 6, 2015 | May 14, 2014 | — | latest (3) | — |
| Apogee Enterprises, Inc. | Settled (agreement with the company) | Nov 12, 2019 | Apr 17, 2018 | — | latest (2) | — |
| Innerworkings Inc | Settled (agreement with the company) | Aug 9, 2019 | Aug 9, 2019 | — | latest (1) | — |
| Del Frisco's Restaurant Group, Inc. | Settled (agreement with the company) | Feb 4, 2019 | Dec 6, 2018 | — | latest (3) | — |
| Benchmark Electronics IncBoard seats | Settled (agreement with the company) | Dec 21, 2016 | Feb 26, 2016 | Proxy contest filed | latest (21) | — |
| Aratana Therapeutics, Inc.Board seats | Settled — 3 board seats | May 21, 2018 | Apr 5, 2018 | — | latest (2) | — |
| Hain Celestial Group Inc | Settled (agreement with the company) | Sep 28, 2017 | Jun 29, 2017 | — | latest (2) | — |
| Outerwall Inc | Settled (agreement with the company) | Apr 12, 2016 | Feb 8, 2016 | — | latest (3) | — |
| HeartWare International, Inc.Board seats | Settled (agreement with the company) | Jan 28, 2016 | Dec 31, 2015 | Proxy contest filed (preliminary proxy) | latest (4) | — |
| Rovi CorpBoard seats | No campaign filings in the last 12 months | May 8, 2015 | Mar 12, 2015 | Proxy contest filed | latest (13) | — |
| Trimas Corp | Settled (agreement with the company) | Feb 25, 2015 | Feb 25, 2015 | — | latest (1) | — |
| Oplink Communications IncBoard seats | No campaign filings in the last 12 months | Nov 6, 2014 | Jul 14, 2014 | Proxy contest filed (preliminary proxy) | latest (6) | — |
| Rentech Inc /Co/ | No campaign filings in the last 12 months | Mar 27, 2014 | Jan 13, 2014 | Soliciting material filed | latest (8) | — |
| Company | Last stake | Source | Outcome | Date |
|---|---|---|---|---|
| BlackLine, Inc. | 1.42% | 13F, quarter ended Jun 30, 2026filed Aug 14, 2026; % of shares outstanding as of Jul 31, 2026 | Not in the latest 13F | Nov 16, 2026 |
| Freshpet, Inc. | 1.01% | 13F, quarter ended Jun 30, 2026filed Aug 14, 2026; % of shares outstanding as of Jul 31, 2026 | Not in the latest 13F | Nov 16, 2026 |
| Nevro Corp | 1.5% | Schedule 13D/A, filed Nov 14, 2024 | Reported below 5% in a 13D/A | Nov 14, 2024 |
| Upbound Group, Inc. | — | Schedule 13D/A, filed Dec 13, 2023stake not read from this filing’s format: see the filing | Not in the 13F for the quarter ended Sep 30, 2024 | Nov 14, 2024 |
| Pra Group Inc | 5.0% | Schedule 13D/A, filed Feb 16, 2024 | Reported below 5% in a 13D/A | Feb 16, 2024 |
| Quotient Technology Inc. | 5.0% | Schedule 13D/A, filed Jul 7, 2023 | Reported below 5% in a 13D/A | Jul 7, 2023 |
Fund votes come from Form N-PX filings, which this site holds from July 1, 2023 (meetings through June 30, 2026; later meetings appear when the managers file their next N-PX); earlier contests and campaigns that settled before a vote are listed under the activist’s campaigns.
No proxy contest has gone to a vote since July 1, 2023.
How each campaign on record ended, as read from the filings: settlements disclosed in the company’s 8-K or the investor’s 13D, contested votes (8-K Item 5.07), withdrawals and 13D amendments below 5%.
| Company | Outcome | Detail | Date | First filing |
|---|---|---|---|---|
| Blackline, Inc. | Settlement | agreement with the company | Mar 10, 2026 | Jan 13, 2026 |
| Portillo's Inc. | Settlement | agreement with the company | Apr 28, 2025 | Aug 15, 2024 |
| YETI Holdings, Inc. | Settlement with board seats | 2 board seats | Mar 17, 2025 | Mar 17, 2025 |
| Evolent Health, Inc. | Settlement | agreement with the company | Feb 4, 2025 | Aug 20, 2020 |
| Nevro Corp | Settlement | agreement with the company | Feb 21, 2024 | Dec 11, 2023 |
| Quotient Technology Inc. | Settlement | agreement with the company | Jun 6, 2023 | Nov 17, 2021 |
| Shake Shack Inc. | Settlement | agreement with the company | May 16, 2023 | May 16, 2023 |
| Upbound Group, Inc. | Settlement | agreement with the company | May 29, 2018 | Jan 30, 2017 |
| New Relic, Inc. | Settlement | agreement with the company | Jun 25, 2021 | Jun 25, 2021 |
| OneSpan Inc. | Settlement | agreement with the company | May 20, 2021 | May 20, 2021 |
| Medifast Inc | Settlement | agreement with the company | Apr 6, 2015 | May 14, 2014 |
| Apogee Enterprises, Inc. | Settlement | agreement with the company | Nov 12, 2019 | Apr 17, 2018 |
| Innerworkings Inc | Settlement | agreement with the company | Aug 9, 2019 | Aug 9, 2019 |
| Del Frisco's Restaurant Group, Inc. | Settlement | agreement with the company | Aug 5, 2019 | Dec 6, 2018 |
| Benchmark Electronics Inc | Settlement | agreement with the company | Feb 26, 2019 | Feb 26, 2016 |
| Aratana Therapeutics, Inc. | Settlement with board seats | 3 board seats | May 21, 2018 | Apr 5, 2018 |
| Hain Celestial Group Inc | Settlement | agreement with the company | Sep 28, 2017 | Jun 29, 2017 |
| Outerwall Inc | Settlement | agreement with the company | Aug 5, 2016 | Feb 8, 2016 |
| HeartWare International, Inc. | Settlement | agreement with the company | Jan 28, 2016 | Dec 31, 2015 |
| Rovi Corp | No outcome in the filings read | — | May 8, 2015 | Mar 12, 2015 |
| Trimas Corp | Settlement | agreement with the company | Feb 25, 2015 | Feb 25, 2015 |
| Oplink Communications Inc | No outcome in the filings read | — | Nov 6, 2014 | Jul 14, 2014 |
| Rentech Inc /Co/ | No outcome in the filings read | — | Mar 27, 2014 | Jan 13, 2014 |
The change in the company’s closing share price from the first trading day on or before the investor’s first Schedule 13D to the latest close, and to 6 and 12 months after it, beside the S&P 500 (SPY) over the same dates. This is a price change after a filing date: it is not attributed to the investor, and it is not the investor’s return. Coverage: 0 of 5 13D positions have prices (the site’s daily price history starts November 10, 2025, and covers only listed tickers it tracks).
Terms of the cooperation agreements, read by rules from the company’s Form 8-K (or the investor’s 13D where it describes the agreement). Each term is quoted from the filing; terms a rule did not find are not listed, so a missing term is not evidence that the agreement lacks it.
“(iii) Concurrently with the appointment of Ms. Prichard to the Board, she shall be appointed to each of the Compensation Committee of the Board and Technology and Cybersecurity Committee of the Board, and shall be entitled to serve on such committees at least until the end of the Restricted Period.” 8-K, Mar 10, 2026
“…Committee and the Board in their respective sole discretion, must be reasonably acceptable to the Engaged Group, and must satisfy certain director criteria; ● At any stockholder meeting or action by written consent, the Engaged Group will vote all shares of Company common stock and other voting securities beneficially owned by them of which they have the right or ability to vote as of the record date in favor of the nominees for director recommended by the Board and in accor…” 8-K, Apr 28, 2025
“The Cooperation Agreement further provides, among other things, that: · During the term of the Cooperation Agreement, Engaged Capital will be subject to customary standstill restrictions, including with respect to acquiring beneficial ownership (including notional shares associated with derivatives) in the aggregate of more than 9.9% of the Company’s common stock, nominating or recommending for nomination any persons for election to the Board, submitting any proposal for cons…” 8-K, Mar 17, 2025
“…ing any “withhold,” “vote no” or similar campaign). · Engaged Capital is deemed to have withdrawn its notice of nomination to the Company dated as of February 4, 2025, in respect of its intention to nominate, and to solicit proxies for the election of, two individuals as director candidates to the Board at the Company’s 2025 Annual Meeting of Stockholders (the “ 2025 Annual Meeting ”). · During the term of the Cooperation Agreement, Engaged Capital will vote all of its shares…” 8-K, Mar 17, 2025
“…licit proxies for the election of, two individuals as director candidates to the Board at the Company’s 2025 Annual Meeting of Stockholders (the “ 2025 Annual Meeting ”). · During the term of the Cooperation Agreement, Engaged Capital will vote all of its shares of the Company’s common stock at all annual and special meetings (of which it has the right to vote as of the applicable record date for such meeting) as well as in any consent solicitations of the Company’s stockhold…” 8-K, Mar 17, 2025
“Pursuant to the Cooperation Agreement, the board of directors of the Company (the “ Board ”) agreed, subject to the terms and conditions set forth in the Cooperation Agreement, to (1) appoint Mr. Brendan Springstubb to the Board with a term expiring at the Company’s 2025 annual meeting of stockholders (the “ 2025 Annual Meeting ”) and (2) appoint Mr. Springstubb to (A) the Strategy Committee of the Board, effective immediately, and (B) either the Audit Committee of the Board…” 8-K, Feb 4, 2025
“The Cooperation Agreement further provides, among other things, that: • During the term of the Cooperation Agreement, Engaged Capital will be subject to customary standstill restrictions, including with respect to acquiring beneficial ownership (including notional shares associated with derivatives) in the aggregate of more than 9.9% of the Company’s Class A common stock, nominating or recommending for nomination any persons for election to the Board (except as expressly perm…” 8-K, Feb 4, 2025
“…d soliciting any proxy, consent or other authority to vote from stockholders or conducting any other referendum (including any “withhold,” “vote no” or similar campaign). • During the term of the Cooperation Agreement, Engaged Capital will vote all of its shares of the Company’s Class A common stock at all annual and special meetings as well as in any consent solicitations of the Company’s stockholders (1) in favor of the slate of directors recommended by the Board, against o…” 8-K, Feb 4, 2025
“Pursuant to the Cooperation Agreement, the board of directors of the Company (the “ Board ”) (1) appointed Mr. Craig A. Barbarosh to the Board as a Class III director with a term expiring at the Company’s 2021 annual meeting of stockholders (the “ 2021 Annual Meeting ”) and (2) appointed Mr. Barbarosh to the Compensation Committee of the Board.” 8-K, Dec 22, 2020
“Pursuant to the Cooperation Agreement described above in Item 1.01, on December 21, 2020, the Board (1) appointed Mr. Craig Barbarosh to the Board as a Class III director with a term expiring at the 2021 Annual Meeting and (2) appointed Mr. Barbarosh to the Compensation Committee of the Board.” 8-K, Dec 22, 2020
“…or of the Company, subject to the approval of the Board, which cannot be unreasonably withheld. • During the term of the Cooperation Agreement, Engaged Capital will be subject to customary standstill restrictions, including with respect to acquiring beneficial ownership in the aggregate of more than 12.0% of the Company’s Class A common stock, nominating or recommending for nomination any persons for election to the Board (except as expressly permitted by the Cooperation Agre…” 8-K, Dec 22, 2020
“…d soliciting any proxy, consent or other authority to vote from stockholders or conducting any other referendum (including any “withhold,” “vote no” or similar campaign). • During the term of the Cooperation Agreement, Engaged Capital will vote all of its shares of the Company’s Class A common stock at all annual and special meetings as well as in any consent solicitations of the Company’s stockholders (1) in favor of the slate of directors recommended by the Board, against o…” 8-K, Dec 22, 2020
“On February 20, 2024, the Board appointed Kirt Karros to the Board, effective immediately.” 8-K, Feb 21, 2024
“Pursuant to the Cooperation Agreement, the Company has agreed to take such actions as are necessary to (i) increase the size of the Company’s board of directors (the “Board”) from ten (10) to eleven (11) directors, (ii) appoint Kirt P. Karros (the “New Director”), to the Board effective immediately, with a term expiring at the 2024 annual meeting of the Company’s stockholders (the “2024 Annual Meeting”) and (iii) include the New Director, Michael DeMane, D. Keith Grossman, Sr…” 8-K, Feb 21, 2024
“Under the standstill restrictions, the Engaged Group may not, among other things and subject to certain exceptions, engage in transactions resulting in the Engaged Group’s beneficial or other ownership interest in the Company’s common stock in excess of 9.9%; publicly propose, suggest or recommend a proposal for an Extraordinary Transaction involving the Company without the prior written approval of the Board; publicly seek to amend any provision of the Company’s charter, byl…” 8-K, Feb 21, 2024
“EX-99.1 6 tm2315964d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Shake Shack Enters Into Cooperation Agreement with Engaged Capital Appoints Jeffrey D. Lawrence to its Board of Directors Agrees to Add One Additional Mutually Agreed Director with Restaurant Operations Experience Company to Engage Operational Consulting Firm and Enhance Corporate Governance New York, May 16, 2023 – Shake Shack Inc. (“Shake Shack” or the “Company”) (NYSE: SHAK) today announced that it has entered a co…” 8-K, May 16, 2023
“As part of the cooperation agreement, the Company appointed Matthew O’Grady as a Class II director and Joseph Reece as a Class III director to its Board of Directors.” 8-K, May 18, 2022
“…tor Company enters into cooperation agreement with Engaged Capital Company announces plan to declassify Board of Directors SAN FRANCISCO – June 25, 2021 – New Relic, Inc. (NYSE: NEWR), the observability company, today announced that it has appointed RK Mahendran, partner at HMI Capital Management L.P. (“HMI Capital”), the largest institutional shareholder in New Relic, to its Board of Directors, effective on June 24, 2021.” 8-K, Jun 25, 2021
“…t three of Legion’s nominees would be added to the Board; that Mr. Cullinane would step down from the Board immediately; and that an additional three unidentified incumbent directors would not stand for re - election April 2021 , the Board appointed Garry Capers to the Board, noting his highly relevant experience, given his P&L and operational responsibility for SaaS solutions primarily targeted at end markets in the financial services industry and his experience lea din g Eq…” 8-K, May 20, 2021
“…• In the press release announcing Mr. Hunt’s retirement, the Company emphasized that the recent Board refreshment also prepares the Board for the future retirement of long - tenured directors September 2020 “We would like to recommend the appointment of Legion Partners’ Senior Analyst, Sagar Gupta, to the Board.” 8-K, May 20, 2021
“…approval of the Nominating and Corporate Governance Committee of the Board and Engaged Capital; • during the term of the Cooperation Agreement, Engaged Capital will be subject to customary standstill restrictions, including with respect to acquiring beneficial ownership of more than 9.9% of the Common Stock, nominating or recommending for nomination any persons for election to the Board (except as expressly permitted by the Cooperation Agreement), submitting any proposal for…” 8-K, Nov 12, 2019
“…d soliciting any proxy, consent or other authority to vote from shareholders or conducting any other referendum (including any “withhold,” “vote no” or similar campaign); • during the term of the Cooperation Agreement, Engaged Capital will vote all of its shares of Common Stock at all annual and special meetings as well as in any consent solicitations of the Company’s shareholders, (1) in favor of the slate of directors recommended by the Board, against the election of any di…” 8-K, Nov 12, 2019
“Pursuant to the Cooperation Agreement described above in Item 1.01, on August 9, 2019, the Board increased its size from nine to 11 directors and appointed Kirt P. Karros and Marc Zenner to the Board.” 8-K, Aug 9, 2019
“Effective upon execution and delivery of the Cooperation Agreement, the board of directors of the Company (the “Board”) (1) increased the size of the Board from nine to 11 members, (2) appointed Kirt P. Karros and Marc Zenner (each a “ New Director ” and collectively, the “ New Directors ”) to the Board with terms expiring at the Company’s 2019 annual meeting of stockholders (the “ 2019 Annual Meeting ”) and (3) appointed Mr. Karros to the Compensation Committee of the Board…” 8-K, Aug 9, 2019
“…ernance Committee and the approval of the Board, neither of which can be unreasonably withheld. • During the term of the Cooperation Agreement, Engaged Capital will be subject to customary standstill restrictions, including with respect to acquiring beneficial ownership of more than 9.9% of the Common Stock, nominating or recommending for nomination any persons for election to the Board (except as expressly permitted by the Cooperation Agreement), submitting any proposal for…” 8-K, Aug 9, 2019
“Mr. Karros was appointed to the Compensation Committee of the Board and Mr. Zenner was appointed to the Audit Committee of the Board.” 8-K, Aug 9, 2019
“…d soliciting any proxy, consent or other authority to vote from stockholders or conducting any other referendum (including any “withhold,” “vote no” or similar campaign). • During the term of the Cooperation Agreement, Engaged Capital will vote all of its shares of the Company’s common stock at all annual and special meetings as well as in any consent solicitations of the Company’s stockholders (1) in favor of the slate of directors recommended by the Board, against the elect…” 8-K, Aug 9, 2019
“I look forward to ongoing discussions with the management and board to help drive additional value for shareholders.” Pursuant to the Cooperation Agreement, Engaged Capital has agreed to vote all of its shares in favor of Benchmark's nominees at its 2019 annual meeting, and has agreed to other customary standstill and voting provisions.” 8-K, Feb 26, 2019
“The terms of the Cooperation Agreement include the appointment of Joe Reece to the Board, which will be expanded by one member to seven directors, and as the Chairman of the Transaction Committee that is overseeing the Company’s previously-announced review of strategic alternatives.” 8-K, Feb 4, 2019
“Engaged Capital will vote all of its shares in favor of the Company’s nominees and other proposals at any meeting of the Company’s shareholders during the cooperation period, subject to certain exceptions.” 8-K, Feb 4, 2019
“…se to be purchased or otherwise acquire (A) beneficial ownership of any common stock or other securities of the Company if immediately after the taking of such action, the Engaged Group together with its Affiliates would, in the aggregate, beneficially own more than 9.9% of the then outstanding shares of common stock of the Company, or (B) interests in any of the Company’s indebtedness. The Engaged Group has irrevocably withdrawn its letter, submitted on March 23, 2018, nom…” 8-K, May 21, 2018
“…e, beneficially own more than 9.9% of the then outstanding shares of common stock of the Company, or (B) interests in any of the Company’s indebtedness. The Engaged Group has irrevocably withdrawn its letter, submitted on March 23, 2018, nominating three director candidates for election to the Board at the 2018 Annual Meeting.” 8-K, May 21, 2018
“…subject to certain exceptions as provided in the Cooperation Agreement, the Engaged Group has agreed that it will, and will cause each of its Affiliates to, appear in person or by proxy at each annual or special meeting of stockholders and vote all shares of c ommon s tock of the Company beneficially owned by the Engaged Group or such Affiliate (or otherwise for which it has voting rights) at such meeting (A) in favor of the slate of directors recommended by the Board and (B)…” 8-K, May 21, 2018
“In addition, subject to certain exceptions, the Engaged Group agreed to appear in person or by proxy at the 2018 Annual Meeting and any special meeting that may be held prior to the termination of the Cooperation Agreement and to vote all of the voting securities it beneficially owns (i) in favor of the Company’s nominees to the Board, (ii) against any nominees for director not recommended by the Board, (iii) against any proposals to remove any director and (iv) in accordance…” 8-K, Feb 7, 2018
“Under the terms of the Cooperation Agreement, Outerwall has appointed Jeffrey J. Brown, Chief Executive Officer and founding member of Brown Equity Partners, LLC, to its Board of Directors, effective immediately.” 8-K, Apr 12, 2016
“Pursuant to the Cooperation Agreement, Engaged Capital has agreed to vote all of its shares in favor of Outerwall’s nominees at the 2016 Annual Meeting of Stockholders, and has agreed to customary standstill provisions.” 8-K, Apr 12, 2016
“Jeff Brown will be appointed to the Executive and Audit Committees of the Board, Glenn Welling will be appointed to the Special Mergers & Acquisitions and Compensation Committees of the Board and Jori Hartwig will be appointed to the Nomination Committee of the Board.” 8-K, Apr 6, 2015
“Under the Cooperation Agreement, Engaged is subject to certain standstill restrictions during the period from the date of the Cooperation Agreement until the day that is three months following the date of the 2016 Annual Meeting, subject to limited exceptions (such period, the “ Standstill Period ”).” 8-K, Apr 6, 2015
“…ting obligations, including, among other things, that Engaged and its affiliates and associates will not acquire beneficial ownership of 10% or more of the Company’s outstanding common stock or participate in a proxy solicitation, and will vote all voting securities which they are entitled to vote in favor of all directors nominated by the Board and in accordance with the recommendation of the Board on other matters, other than certain specified matters and subject to certain…” 8-K, Apr 6, 2015
“…m TRIMAS APPOINTS HERBERT K. PARKER TO BOARD OF DIRECTORS BLOOMFIELD HILLS, Michigan, February 25, 2015 - TriMas Corporation (NASDAQ: TRS) - a diversified global manufacturer of engineered and applied products - today announced that it has appointed Herbert K. Parker, former chief financial officer and current executive vice president, Operational Excellence at Harman International to its Board of Directors, effective immediately.” 8-K, Feb 25, 2015
Filings by other activists on this list (their first 13D or 13F on the company) and by other holders of 5% or more (Schedule 13D or 13G) dated within 180 days of Engaged Capital’s first disclosure in the same company. They are listed together by date only; nothing here says the holders act together.
| Holder | Form | Date | Stake |
|---|---|---|---|
| Baillie Gifford & Co | Schedule 13G | Feb 12, 2025 | 9.1% |
| BlackRock, Inc. | Schedule 13G | Apr 24, 2025 | 9.1% |
| Wellington Management Group LLP | Schedule 13G | Aug 12, 2025 | 5.9% |
| Wasatch Advisors LP | Schedule 13G | Aug 14, 2025 | 2.3% |
| The Vanguard Group | Schedule 13G | Sep 8, 2025 | 10.3% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| FMR LLC | Schedule 13G | May 12, 2025 | 6.1% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| Magnetar Financial LLC | Schedule 13D | Jul 20, 2023 | 5.4% |